4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001708599-25-000085
Chief Scientific Officer sold 5,500 shares at $5.17 ($28,435)
- Chief Scientific Officer acquired 5,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-08-04 | Option exercise 10b5-1 | +5,500 | $0.06 | $330 | 5,500 | D |
| Moreadith Randall Chief Scientific Officer | 2025-08-04 | Sale 10b5-1 | −5,500 | $5.17 | $28,435 | 0 | D |
| Derivatives | |||||||
| Moreadith Randall Chief Scientific Officer | 2025-08-04 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,500 | 478,990 | D | ||
| Open-market sales · 5,500 sh · avg $5.17 · $28,435 | |||||||
Loading xslF345X05/wk-form4_1754515343.xml…